Cargando…
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity
The coronavirus infectious disease 2019 (COVID-19) pandemic has hit the world, affecting health, medical care, economies and our society as a whole. Furthermore, COVID-19 pandemic joins the increasing prevalence of metabolic syndrome in western countries. Patients suffering from obesity, type II dia...
Autores principales: | Lamadrid, Patricia, Alonso-Peña, Marta, San Segundo, David, Arias-Loste, Mayte, Crespo, Javier, Lopez-Hoyos, Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042647/ https://www.ncbi.nlm.nih.gov/pubmed/33859644 http://dx.doi.org/10.3389/fimmu.2021.651728 |
Ejemplares similares
-
The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
por: Arias-Loste, María Teresa, et al.
Publicado: (2015) -
Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients
por: San Segundo, David, et al.
Publicado: (2021) -
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
por: Santos-Laso, Alvaro, et al.
Publicado: (2021) -
Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy
por: Iglesias-Escudero, María, et al.
Publicado: (2022) -
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease
por: Arias-Loste, María Teresa, et al.
Publicado: (2016)